Genomic screening in children: BabyScreen+

Gene: PCSK9

Green List (high evidence)

PCSK9 (proprotein convertase subtilisin/kexin type 9, Ensemblv90)
EnsemblGeneIds (GRCh38): ENSG00000169174
EnsemblGeneIds (GRCh37): ENSG00000169174
OMIM: 607786, ClinGen, DECIPHER
PCSK9 is in 1 panel

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

STRONG actionability in children by ClinGen.

Elevated LDL-C levels can be detected from infancy and strongly predispose patients with FH to progressive atherosclerosis throughout childhood and premature CVD in adulthood. Although complications of atherosclerosis occur most commonly in individuals aged >50, the pathophysiological processes begin in childhood and are affected by additional risk factors: hypertension, diabetes, smoking, obesity, poor diet, and physical inactivity. By 12 years of age, children with FH have significant thickening of the carotid intima-media, and by 18 years have coronary stenosis. In natural history studies, 50% of males and 25% of females with FH develop clinical CVD by age 50 years, but up to 10% can have severe premature CVD by 40 years of age. On average, individuals with HeFH experience their first coronary event at age 42, 20 years younger than the general population. Statins have changed the prognosis of FH such that the rates of cardiovascular (CV) events are equal to the general population after 10 years of treatment.
Created: 17 Dec 2025, 6:37 p.m. | Last Modified: 17 Dec 2025, 6:37 p.m.
Panel Version: 0.81

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
hypercholesterolemia, autosomal dominant, 3 MONDO:0011369

Sangavi Sivagnanasundram (Melbourne Health)

Green List (high evidence)

Classified as Definitive by ClinGen General Gene Curation GCEP on 14/11/2018 - https://search.clinicalgenome.org/CCID:005746

Mechanism of disease is GoF.
Heterozygous LoF variants in this gene are associated with low levels of LDL cholesterol - PMID: 15654334
Created: 27 Nov 2024, 3:34 p.m. | Last Modified: 27 Nov 2024, 3:34 p.m.
Panel Version: 0.27

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
hypercholesterolemia, autosomal dominant, 3 MONDO:0011369

Publications

Mode of pathogenicity
Other

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • hypercholesterolemia, autosomal dominant, 3 MONDO:0011369
Tags
cardiac treatable
OMIM
607786
ClinGen
PCSK9
DECIPHER
PCSK9
Clinvar variants
Variants in PCSK9
Penetrance
None
Publications
Mode of Pathogenicity
Other
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
21 Jul 2026, Gel status: 3

Added Tag, Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag cardiac tag was added to gene: PCSK9. Tag treatable tag was added to gene: PCSK9.

17 Dec 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: pcsk9 has been classified as Green List (High Evidence).

17 Dec 2025, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set mode of pathogenicity

Zornitza Stark (Victorian Clinical Genetics Services)

gene: PCSK9 was added gene: PCSK9 was added to Genomic screening in children: BabyScreen+. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: PCSK9 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: PCSK9 were set to 24404629; 16577715; 15654334 Phenotypes for gene: PCSK9 were set to hypercholesterolemia, autosomal dominant, 3 MONDO:0011369 Mode of pathogenicity for gene: PCSK9 was set to Other